Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
MAYOR AND CITY COUNCIL OF BALTIMORE v. MERCK SHARP & DOHME CORP.
Case Number:
2:23-cv-00828
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
-
November 21, 2023
Baltimore Merck Vax Suit Proceeds But Utah, Idaho Claims Cut
The bulk of Baltimore's proposed class action against Merck over its rotavirus vaccine bundling can go to class certification, a Pennsylvania federal judge has ruled, finding that Merck may very well have violated antitrust laws through its "loyalty" program for an essential pediatric vaccine, but also tossing two claims under Idaho and Utah antitrust law.
-
May 10, 2023
To Gets Vaccine Bundling Suit Tossed, Merck Points To GSK
Merck & Co. urged a Pennsylvania federal judge to toss the latest proposed class action accusing it of anti-competitively bundling childhood vaccines to protect its rotavirus vaccine, arguing the lawsuit can't get past the bundling capabilities of rival vaccine maker GlaxoSmithKline PLC.
-
March 06, 2023
Merck Hit With 3rd-Party Payor Suit Over Vaccine Bundling
Merck Sharp & Dohme Corp. has been hit with another proposed class action over its allegedly anti-competitive practice of bundling several of its vaccines for children to maintain its monopoly power in the rotavirus vaccine market, this time brought by third-party payors who indirectly paid for or reimbursed rotavirus vaccines.